The Dermatology Digest

FEBRUARY 20, 2024

In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I Obagi has been connected to our brand, in various capacities, since its inception. Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director.

Medical 36

Medical Medical Grade Skincare Portfolios Skincare 36

Spa Executive

MARCH 28, 2024

At Spa Executive and Book4Time, we have had the opportunity to gather insights from leaders at the top luxury hotel & resort spa brands in the world – and asked a great many of them about what makes the best guest and wellness experiences. Design is a core focus for Jumeirah which also extends within the wellness spaces in the portfolio.

Portfolios 74

Portfolios Technology Hospital Treatments 74

Spa Executive

OCTOBER 23, 2024

Hilton’s 2025 Trends Report unveils the rising travel trends predicted to ignite conversation and innovation while reshaping the travel experience in 2025. These findings highlight new opportunities for us to innovate across our global portfolio and further enhance guests’ stays.

Portfolios 52

Portfolios Technology Social Media Branding 52

The Dermatology Digest

OCTOBER 28, 2024

The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.

Portfolios 36

Portfolios Dermatitis Office Partnerships 36

The Dermatology Digest

SEPTEMBER 9, 2024

“These formulations enhance overall skin texture, underscoring our commitment to integrating cutting-edge scientific research and ingredients into practical, effective skincare solutions,” says Eman Kadhim, Head of Scientific Communications & Upstream Innovation at Waldencast, in a news release.

Portfolios 36

Portfolios Dermatology Injections Marketing 36

The Dermatology Digest

JANUARY 2, 2024

Shiseido to Acquire Dr. Dennis Gross Skincare Shiseido Americas Corporation is set to acquire the Dr. Dennis Gross Skincare brand. With the addition of Dr. Dennis Gross Skincare, Shiseido seeks to accelerate and strengthen its core prestige skincare business which includes brands SHISEIDO and Clé de Peau Beauté.

Dermatology 36

Dermatology Sales Skincare Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36

Spa Executive

JUNE 19, 2024

Remington Hospitality, established in 1968, is a premier hotel management company renowned for its innovative and owner-centric approach. Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry.

Hospital 52

Hospital Technology Sustainability Management 52

Spa Executive

AUGUST 27, 2024

Book4Time grew its global footprint, in part, through relationships with global hotel and resort brands; integrations with more than 60 technology providers, including property management systems (PMS) and point-of-sale systems (POS); and its highly efficient remote implementation, training and support capabilities.

Management 52

Management Hospital Technology Sales 52

Aesthetics Advisor

SEPTEMBER 15, 2023

Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announced today that Carragelose inactivates the new, rapidly spreading variants and SARS-CoV-2 wildtype with similar efficacy in vitro.

Hospital 69

Hospital Clinic Marketing Medical 69

Spa Executive

OCTOBER 3, 2023

Al-Masri has worked across branding, strategy, development, design, pre-opening, and ongoing operational management. Before her time at Equinox, she served as the Global Director of Spa Development and Operations at Starwood Hotel & Resorts, managing the company’s spa brands, partnerships, and a global portfolio of over 450 spas.

Portfolios 52

Portfolios Hospital Branding Innovations 52

The Eco Well Blog

SEPTEMBER 18, 2022

The company has a service-oriented approach to support brands in launching safe and compliant products on the markets. The company has a service-oriented approach to support brands in launching safe and compliant products on the markets. Dr M has over 20 years of experience in the pharmaceutical, biopharma and cosmetics industries.

Branding 52

Branding Safety Management Pharmaceutical 52

The Eco Well Blog

MAY 16, 2022

Through her science education work, Michelle has worked with a range of brands on campaigns, including Proctor & Gamble and Johnson & Johnson. His current focus is on Sun care, Color cosmetics and Sustainable innovation. Her work has been featured in international magazines including Elle and Huffington Post.

Legal 52

Legal Pharmaceutical Sun Protection Technology 52